School Access to Naloxone Act of 2026
Key claim: The School Access to Naloxone Act of 2026 (HR9251) has been referred to the House Committee on Energy and Commerce, proposing to expand naloxone availability in school settings.
Abstract
(HR9251 · 119th Congress) Latest action (2026-06-10): Referred to the House Committee on Energy and Commerce.
Why this matters
The referral of HR9251 to the House Energy and Commerce Committee marks the first procedural step for a bill that would place naloxone — an opioid overdose reversal medication — into K-12 school settings, potentially creating new obligations or authorities for districts, school nurses, and staff. For schools, the practical implications (training, storage, liability, funding) will depend on committee markup and any linkage to existing federal naloxone distribution programs. The action is incremental but signals continued federal interest in extending opioid harm-reduction infrastructure into education environments.